L. Harman

445 total citations
10 papers, 309 citations indexed

About

L. Harman is a scholar working on Molecular Biology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, L. Harman has authored 10 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in L. Harman's work include Genetic and Kidney Cyst Diseases (4 papers), Renal and related cancers (4 papers) and Biochemical and Molecular Research (3 papers). L. Harman is often cited by papers focused on Genetic and Kidney Cyst Diseases (4 papers), Renal and related cancers (4 papers) and Biochemical and Molecular Research (3 papers). L. Harman collaborates with scholars based in United States, Germany and Finland. L. Harman's co-authors include Jutta Becker, Gregory G. Germino, Luiz F. Onuchic, C. Steinkamm, Juhani Rapola, Ellis D. Avner, Lisa M. Guay‐Woodford, Stefan Somlo, Klaus Zerres and Riitta Salonen and has published in prestigious journals such as Blood, Diabetes Care and Journal of Allergy and Clinical Immunology.

In The Last Decade

L. Harman

10 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Harman United States 6 188 184 50 47 34 10 309
Fenxia Li China 13 229 1.2× 91 0.5× 77 1.5× 35 0.7× 36 1.1× 30 438
Jolanta Szymańska-Pasternak Poland 9 93 0.5× 74 0.4× 7 0.1× 37 0.8× 33 1.0× 15 220
Ekaterina Kuchinskaya Sweden 10 83 0.4× 68 0.4× 40 0.8× 55 1.2× 37 1.1× 28 287
Miguel Inácio da Silva Filho Germany 12 144 0.8× 64 0.3× 12 0.2× 29 0.6× 8 0.2× 24 298
Lixian Chang China 11 134 0.7× 31 0.2× 51 1.0× 26 0.6× 13 0.4× 58 348
Bahram Hosseini‐Maaf Sweden 9 72 0.4× 90 0.5× 85 1.7× 5 0.1× 33 1.0× 13 458
Masaki Toshima Japan 7 155 0.8× 30 0.2× 7 0.1× 24 0.5× 20 0.6× 16 329
Rossana Putzulu Italy 9 157 0.8× 38 0.2× 12 0.2× 32 0.7× 17 0.5× 26 295
Janna A. Hol Netherlands 11 192 1.0× 40 0.2× 103 2.1× 18 0.4× 24 0.7× 22 310
Debora Lúcia Seguro Danilovic Brazil 12 114 0.6× 87 0.5× 10 0.2× 41 0.9× 123 3.6× 27 423

Countries citing papers authored by L. Harman

Since Specialization
Citations

This map shows the geographic impact of L. Harman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Harman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Harman more than expected).

Fields of papers citing papers by L. Harman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Harman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Harman. The network helps show where L. Harman may publish in the future.

Co-authorship network of co-authors of L. Harman

This figure shows the co-authorship network connecting the top 25 collaborators of L. Harman. A scholar is included among the top collaborators of L. Harman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Harman. L. Harman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Harman, L., et al.. (2013). A Simple, Sensitive and Selective Fluorogenic Assay to Monitor Kallikrein Activity in Activated Plasma. Journal of Allergy and Clinical Immunology. 131(2). AB210–AB210. 1 indexed citations
2.
Harman, L., et al.. (2012). FRI0401 BCX4208, a novel enzyme inhibitor for chronic management of GOUT, shows a low risk of potential drug-drug interactions. Annals of the Rheumatic Diseases. 71. 450–450. 3 indexed citations
3.
Parker, Charles, et al.. (2012). OP0106 Effect of BCX4208 add-on therapy to allopurinol 300 mg on plasma hypoxanthine and xanthine concentrations in gout patients. Annals of the Rheumatic Diseases. 71. 89–89. 5 indexed citations
4.
Gandhi, Varsha, John Michael Kilpatrick, William Plunkett, et al.. (2005). A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine). Blood. 106(13). 4253–4260. 79 indexed citations
5.
Zerres, Klaus, Gabi Mücher, Jutta Becker, et al.. (1999). Prenatal Diagnosis of Autosomal Recessive Polycystic Kidney Disease (ARPKD): Molecular Genetics, Clinical Experience, and Fetal Morphology. The Journal of Urology. 161(1). 368–369. 11 indexed citations
6.
Zerres, Klaus, Gabi Mücher, Jutta Becker, et al.. (1999). Prenatal Diagnosis of Autosomal Recessive Polycystic Kidney Disease (ARPKD). The Journal of Urology. 368–369. 1 indexed citations
7.
Zerres, Klaus, Gabi Mücher, Jutta Becker, et al.. (1998). Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): Molecular genetics, clinical experience, and fetal morphology. American Journal of Medical Genetics. 76(2). 137–144. 16 indexed citations
8.
Zerres, Klaus, Jutta Becker, C. Steinkamm, et al.. (1998). Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): Molecular genetics, clinical experience, and fetal morphology. American Journal of Medical Genetics. 76(2). 137–144. 166 indexed citations
9.
Acton, Ronald T., Jeffrey M. Roseman, David S.H. Bell, et al.. (1994). Genes Within the Major Histocompatibility Complex Predict NIDDM in African-American Women in Alabama. Diabetes Care. 17(12). 1491–1494. 7 indexed citations
10.
Acton, Ronald T., L. Harman, Rodney C.P. Go, Mei‐Chiun Tseng, & Wilma Β. Bias. (1993). Comparison of HLA phenotypes among African Americans from Alabama, Maryland, and North Carolina.. PubMed. 25(4). 2404–7. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026